Handbook of Experimental Pharmacology

Clinical Evidence of Cardioprotective Effects of SGLT2 Inhibitors

By Muhammad Shariq Usman, Subodh Verma, Ambarish Pandey

ReviewInterventions

The paper

Muhammad Shariq Usman, Subodh Verma, Ambarish Pandey

The University of Texas Southwestern Medical Center; University of Michigan

Handbook of Experimental Pharmacology, 13 Sep 2026

doi.org/10.1007/164_2026_827 PubMed 42730804

The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes